Eisai Co Ltd - Strategy, SWOT and Corporate Finance Report

Eisai Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Eisai Co Ltd (Eisai) is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals, including over-the-counter (OTC) drugs, prescription medicines and generics. The company’s franchise areas in research include neurology and oncology. Eisai’s major products include Pariet/AcipHex (proton pump inhibitor); Aricept, an anti-Alzheimer's agent; Halaven, a novel anti-cancer agent; Fycompa, an anti-epileptic and peripheral neuropathy treatment, among others. Eisai has production plants in Japan, the UK, China and India and laboratories in Japan, the US and the UK; overseas sales offices in the US, Germany, France, China and South Korea. Eisai is headquartered in Tokyo, Japan.

Scope

  • Detailed information on Eisai Co Ltd required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Eisai Co Ltd in the form of a SWOT analysis
  • An in-depth view of the business model of Eisai Co Ltd including a breakdown and examination of key business segments
  • News about Eisai Co Ltd, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Eisai Co Ltd and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Eisai Co Ltd as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Eisai Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Cassava Sciences Inc

Ono Pharmaceutical Co Ltd

Nippon Kayaku Co Ltd

Daiichi Sankyo Inc

Chugai Pharmaceutical Co Ltd

Astellas Pharma Inc

Mochida Pharmaceutical Co Ltd

Cassava Sciences Inc

Ono Pharmaceutical Co Ltd

Nippon Kayaku Co Ltd

Daiichi Sankyo Inc

Chugai Pharmaceutical Co Ltd

Astellas Pharma Inc

Mochida Pharmaceutical Co Ltd

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Eisai Co Ltd - Key Facts

Eisai ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Eisai Co Ltd - Key Facts

Eisai Co Ltd - Key Employees

Eisai Co Ltd - Key Employee Biographies

Eisai Co Ltd - Major Products and Services

Eisai Co Ltd - History

Eisai Co Ltd - Company Statement

Eisai Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Company Overview

Eisai Co Ltd - Business Description

Product Category: Neurology Products

Overview

Performance

Product Category: Oncology Products

Overview

Performance

Product Category: Others

Performance

Product Category: Americas Pharmaceutical Business

Overview

Performance

Product Category: Asia and Latin America Pharmaceutical Business

Overview

Performance

Product Category: China Pharmaceutical Business

Overview

Performance

Product Category: EMEA Pharmaceutical Business

Overview

Performance

Product Category: Japan Pharmaceutical Business

Overview

Performance

Product Category: Other Business

Overview

Performance

R&D Overview

Eisai Co Ltd - Corporate Strategy

Eisai Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Eisai Co Ltd - Strengths

Eisai Co Ltd - Weaknesses

Eisai Co Ltd - Opportunities

Eisai Co Ltd - Threats

Eisai Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Eisai Co Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jul 10, 2019: Eisai Center for Genetics Guided Dementia Discovery commences full-scale operation toward innovative dementia treatments with new drug discovery approach in Cambridge, Massachusetts

Jul 08, 2019: Eisai forms PROTACs research collaboration

May 09, 2019: Eisai commences venture investment business aimed at accelerating innovation in Drug Creation and Establishment of Ecosystem Platform

May 09, 2019: Eisai and Allm enter into Capital and Business Alliance Agreement for ICT Healthcare Solutions

May 08, 2019: Eisai and the UK Dementia Research Institute jointly launch new post-doctoral programme to accelerate Dementia research

May 08, 2019: Eisai and UK Dementia research institute jointly launch new post-doctoral programme to accelerate dementia research

Apr 24, 2019: Eisai selected as competitive ICT strategy company 2019

Jan 22, 2019: Eisai listed as Global 100 most sustainable corporation for the fourth time

Dec 12, 2018: GARDP, Eisai and Takeda join forces to identify new antibiotics

Nov 14, 2018: EISAI Receives IR GRAND PRIX award second IR GRAND PRIX award since 2006

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Eisai Co Ltd, Key Facts

Eisai Co Ltd, Key Employees

Eisai Co Ltd, Key Employee Biographies

Eisai Co Ltd, Major Products and ...

List of Tables

Eisai Co Ltd, Key Facts

Eisai Co Ltd, Key Employees

Eisai Co Ltd, Key Employee Biographies

Eisai Co Ltd, Major Products and Services

Eisai Co Ltd, History

Eisai Co Ltd, Subsidiaries

Eisai Co Ltd, Joint Venture

Eisai Co Ltd, Key Competitors

Eisai Co Ltd, Ratios based on current share price

Eisai Co Ltd, Annual Ratios

Eisai Co Ltd, Annual Ratios (Cont...1)

Eisai Co Ltd, Annual Ratios (Cont...2)

Eisai Co Ltd, Interim Ratios

Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Eisai Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Eisai Co Ltd, Performance Chart (2015 - 2019)

Eisai Co Ltd, Ratio Charts

Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, ...

List of Figures

Eisai Co Ltd, Performance Chart (2015 - 2019)

Eisai Co Ltd, Ratio Charts

Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports